866-997-4948(US-Canada Toll Free)

Europe T-Cell Immunotherapy Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 122 Pages

Notes:
Sales, means the sales volume of T-Cell Immunotherapy
Revenue, means the sales value of T-Cell Immunotherapy

This report studies sales (consumption) of T-Cell Immunotherapy in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Adaptimmune
Altor Bioscience Corporation
Cellectis
Cell Therapy Catapult
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
Abingworth
ARCH Venture Partners
Acorn Campus Ventures
Adaptimmune
AFA F?rs?kring
AGF Private Equity
AgonOx
Agreen Biotech
Aju IB Investment
Alaska Permanent Fund
Alexandria Ventures
Allos Therapeutics
Amgen
Applied Immune Technologies
Aquilo Capital Management

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of T-Cell Immunotherapy in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
CAR-T
TCR
TIL Therapies

Split by application, this report focuses on sales, market share and growth rate of T-Cell Immunotherapy in each application, can be divided into
Hematological Malignancies
Solid Tumors
Others

Table of Contents

Europe T-Cell Immunotherapy Market Report 2017
1 T-Cell Immunotherapy Overview
1.1 Product Overview and Scope of T-Cell Immunotherapy
1.2 Classification of T-Cell Immunotherapy
1.2.1 CAR-T
1.2.2 TCR
1.2.3 TIL Therapies
1.3 Application of T-Cell Immunotherapy
1.3.1 Hematological Malignancies
1.3.2 Solid Tumors
1.3.3 Others
1.4 T-Cell Immunotherapy Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of T-Cell Immunotherapy (2012-2022)
1.5.1 Europe T-Cell Immunotherapy Sales and Growth Rate (2012-2022)
1.5.2 Europe T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

2 Europe T-Cell Immunotherapy by Manufacturers, Type and Application
2.1 Europe T-Cell Immunotherapy Market Competition by Manufacturers
2.1.1 Europe T-Cell Immunotherapy Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe T-Cell Immunotherapy Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe T-Cell Immunotherapy (Volume and Value) by Type
2.2.1 Europe T-Cell Immunotherapy Sales and Market Share by Type (2012-2017)
2.2.2 Europe T-Cell Immunotherapy Revenue and Market Share by Type (2012-2017)
2.3 Europe T-Cell Immunotherapy (Volume and Value) by Countries
2.3.1 Europe T-Cell Immunotherapy Sales and Market Share by Countries (2012-2017)
2.3.2 Europe T-Cell Immunotherapy Revenue and Market Share by Countries (2012-2017)
2.4 Europe T-Cell Immunotherapy (Volume) by Application

3 Germany T-Cell Immunotherapy (Volume, Value and Sales Price)
3.1 Germany T-Cell Immunotherapy Sales and Value (2012-2017)
3.1.1 Germany T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
3.1.2 Germany T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
3.1.3 Germany T-Cell Immunotherapy Sales Price Trend (2012-2017)
3.2 Germany T-Cell Immunotherapy Sales and Market Share by Manufacturers
3.3 Germany T-Cell Immunotherapy Sales and Market Share by Type
3.4 Germany T-Cell Immunotherapy Sales and Market Share by Application

4 France T-Cell Immunotherapy (Volume, Value and Sales Price)
4.1 France T-Cell Immunotherapy Sales and Value (2012-2017)
4.1.1 France T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
4.1.2 France T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
4.1.4 France T-Cell Immunotherapy Sales Price Trend (2012-2017)
4.2 France T-Cell Immunotherapy Sales and Market Share by Manufacturers
4.3 France T-Cell Immunotherapy Sales and Market Share by Type
4.4 France T-Cell Immunotherapy Sales and Market Share by Application

5 UK T-Cell Immunotherapy (Volume, Value and Sales Price)
5.1 UK T-Cell Immunotherapy Sales and Value (2012-2017)
5.1.1 UK T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
5.1.2 UK T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
5.1.5 UK T-Cell Immunotherapy Sales Price Trend (2012-2017)
5.2 UK T-Cell Immunotherapy Sales and Market Share by Manufacturers
5.3 UK T-Cell Immunotherapy Sales and Market Share by Type
5.4 UK T-Cell Immunotherapy Sales and Market Share by Application

6 Russia T-Cell Immunotherapy (Volume, Value and Sales Price)
6.1 Russia T-Cell Immunotherapy Sales and Value (2012-2017)
6.1.1 Russia T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
6.1.2 Russia T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
6.1.6 Russia T-Cell Immunotherapy Sales Price Trend (2012-2017)
6.2 Russia T-Cell Immunotherapy Sales and Market Share by Manufacturers
6.3 Russia T-Cell Immunotherapy Sales and Market Share by Type
6.4 Russia T-Cell Immunotherapy Sales and Market Share by Application

7 Italy T-Cell Immunotherapy (Volume, Value and Sales Price)
7.1 Italy T-Cell Immunotherapy Sales and Value (2012-2017)
7.1.1 Italy T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
7.1.2 Italy T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
7.1.7 Italy T-Cell Immunotherapy Sales Price Trend (2012-2017)
7.2 Italy T-Cell Immunotherapy Sales and Market Share by Manufacturers
7.3 Italy T-Cell Immunotherapy Sales and Market Share by Type
7.4 Italy T-Cell Immunotherapy Sales and Market Share by Application

8 Spain T-Cell Immunotherapy (Volume, Value and Sales Price)
8.1 Spain T-Cell Immunotherapy Sales and Value (2012-2017)
8.1.1 Spain T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
8.1.2 Spain T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
8.1.8 Spain T-Cell Immunotherapy Sales Price Trend (2012-2017)
8.2 Spain T-Cell Immunotherapy Sales and Market Share by Manufacturers
8.3 Spain T-Cell Immunotherapy Sales and Market Share by Type
8.4 Spain T-Cell Immunotherapy Sales and Market Share by Application

9 Benelux T-Cell Immunotherapy (Volume, Value and Sales Price)
9.1 Benelux T-Cell Immunotherapy Sales and Value (2012-2017)
9.1.1 Benelux T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
9.1.2 Benelux T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
9.1.9 Benelux T-Cell Immunotherapy Sales Price Trend (2012-2017)
9.2 Benelux T-Cell Immunotherapy Sales and Market Share by Manufacturers
9.3 Benelux T-Cell Immunotherapy Sales and Market Share by Type
9.4 Benelux T-Cell Immunotherapy Sales and Market Share by Application

10 Europe T-Cell Immunotherapy Manufacturers Analysis
10.1 Adaptimmune
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 T-Cell Immunotherapy Product Type, Application and Specification
10.1.2.1 CAR-T
10.1.2.2 TCR
10.1.3 Adaptimmune T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Altor Bioscience Corporation
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 T-Cell Immunotherapy Product Type, Application and Specification
10.2.2.1 CAR-T
10.2.2.2 TCR
10.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Cellectis
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 T-Cell Immunotherapy Product Type, Application and Specification
10.3.2.1 CAR-T
10.3.2.2 TCR
10.3.3 Cellectis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Cell Therapy Catapult
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 T-Cell Immunotherapy Product Type, Application and Specification
10.4.2.1 CAR-T
10.4.2.2 TCR
10.4.3 Cell Therapy Catapult T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Juno Therapeutics
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 T-Cell Immunotherapy Product Type, Application and Specification
10.5.2.1 CAR-T
10.5.2.2 TCR
10.5.3 Juno Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Kite Pharma
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 T-Cell Immunotherapy Product Type, Application and Specification
10.6.2.1 CAR-T
10.6.2.2 TCR
10.6.3 Kite Pharma T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Novartis
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 T-Cell Immunotherapy Product Type, Application and Specification
10.7.2.1 CAR-T
10.7.2.2 TCR
10.7.3 Novartis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Takara Bio
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 T-Cell Immunotherapy Product Type, Application and Specification
10.8.2.1 CAR-T
10.8.2.2 TCR
10.8.3 Takara Bio T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Unum Therapeutics
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 T-Cell Immunotherapy Product Type, Application and Specification
10.9.2.1 CAR-T
10.9.2.2 TCR
10.9.3 Unum Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Abingworth
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 T-Cell Immunotherapy Product Type, Application and Specification
10.10.2.1 CAR-T
10.10.2.2 TCR
10.10.3 Abingworth T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 ARCH Venture Partners
10.12 Acorn Campus Ventures
10.13 Adaptimmune
10.14 AFA F?rs?kring
10.15 AGF Private Equity
10.16 AgonOx
10.17 Agreen Biotech
10.18 Aju IB Investment
10.19 Alaska Permanent Fund
10.20 Alexandria Ventures
10.21 Allos Therapeutics
10.22 Amgen
10.23 Applied Immune Technologies
10.24 Aquilo Capital Management

11 T-Cell Immunotherapy Manufacturing Cost Analysis
11.1 T-Cell Immunotherapy Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of T-Cell Immunotherapy

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 T-Cell Immunotherapy Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of T-Cell Immunotherapy Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe T-Cell Immunotherapy Market Forecast (2017-2022)
14.1 Germany T-Cell Immunotherapy Sales Forecast (2017-2022)
14.2 France T-Cell Immunotherapy Sales Forecast (2017-2022)
14.3 UK T-Cell Immunotherapy Sales Forecast (2017-2022)
14.4 Russia T-Cell Immunotherapy Sales Forecast (2017-2022)
14.5 Italy T-Cell Immunotherapy Sales Forecast (2017-2022)
14.6 Spain T-Cell Immunotherapy Sales Forecast (2017-2022)
14.7 Benelux T-Cell Immunotherapy Sales Forecast (2017-2022)
14.8 Europe T-Cell Immunotherapy Sales Forecast by Type (2017-2022)
14.9 Europe T-Cell Immunotherapy Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of T-Cell Immunotherapy
Table Classification of T-Cell Immunotherapy
Figure Europe Sales Market Share of T-Cell Immunotherapy by Type in 2015
Figure CAR-T Picture
Figure TCR Picture
Figure TIL Therapies Picture
Table Application of T-Cell Immunotherapy
Figure Europe Sales Market Share of T-Cell Immunotherapy by Application in 2015
Figure Hematological Malignancies Examples
Figure Solid Tumors Examples
Figure Others Examples
Figure Germany T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Figure France T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Figure UK T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Figure Russia T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Figure Italy T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Figure Spain T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Figure Benelux T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Figure Europe T-Cell Immunotherapy Sales and Growth Rate (2012-2022)
Figure Europe T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Table Europe T-Cell Immunotherapy Sales of Key Manufacturers (2015 and 2016)
Table Europe T-Cell Immunotherapy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 T-Cell Immunotherapy Sales Share by Manufacturers
Figure 2016 T-Cell Immunotherapy Sales Share by Manufacturers
Table Europe T-Cell Immunotherapy Revenue by Manufacturers (2015 and 2016)
Table Europe T-Cell Immunotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe T-Cell Immunotherapy Revenue Share by Manufacturers
Table 2016 Europe T-Cell Immunotherapy Revenue Share by Manufacturers
Table Europe T-Cell Immunotherapy Sales and Market Share by Type (2012-2017)
Table Europe T-Cell Immunotherapy Sales Share by Type (2012-2017)
Figure Sales Market Share of T-Cell Immunotherapy by Type (2012-2017)
Figure Europe T-Cell Immunotherapy Sales Growth Rate by Type (2012-2017)
Table Europe T-Cell Immunotherapy Revenue and Market Share by Type (2012-2017)
Table Europe T-Cell Immunotherapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of T-Cell Immunotherapy by Type (2012-2017)
Figure Europe T-Cell Immunotherapy Revenue Growth Rate by Type (2012-2017)
Table Europe T-Cell Immunotherapy Sales and Market Share by Countries (2012-2017)
Table Europe T-Cell Immunotherapy Sales Share by Countries (2012-2017)
Figure Sales Market Share of T-Cell Immunotherapy by Countries (2012-2017)
Table Europe T-Cell Immunotherapy Revenue and Market Share by Countries (2012-2017)
Table Europe T-Cell Immunotherapy Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of T-Cell Immunotherapy by Countries (2012-2017)
Table Europe T-Cell Immunotherapy Sales and Market Share by Application (2012-2017)
Table Europe T-Cell Immunotherapy Sales Share by Application (2012-2017)
Figure Sales Market Share of T-Cell Immunotherapy by Application (2012-2017)
Figure Germany T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
Figure Germany T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Germany T-Cell Immunotherapy Sales Price Trend (2012-2017)
Table Germany T-Cell Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Germany T-Cell Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Germany T-Cell Immunotherapy Sales by Type (2015 and 2016)
Table Germany T-Cell Immunotherapy Market Share by Type (2015 and 2016)
Table Germany T-Cell Immunotherapy Sales by Application (2015 and 2016)
Table Germany T-Cell Immunotherapy Market Share by Application (2015 and 2016)
Figure France T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
Figure France T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
Figure France T-Cell Immunotherapy Sales Price Trend (2012-2017)
Table France T-Cell Immunotherapy Sales by Manufacturers (2015 and 2016)
Table France T-Cell Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table France T-Cell Immunotherapy Sales by Type (2015 and 2016)
Table France T-Cell Immunotherapy Market Share by Type (2015 and 2016)
Table France T-Cell Immunotherapy Sales by Application (2015 and 2016)
Table France T-Cell Immunotherapy Market Share by Application (2015 and 2016)
Figure UK T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
Figure UK T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
Figure UK T-Cell Immunotherapy Sales Price Trend (2012-2017)
Table UK T-Cell Immunotherapy Sales by Manufacturers (2015 and 2016)
Table UK T-Cell Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table UK T-Cell Immunotherapy Sales by Type (2015 and 2016)
Table UK T-Cell Immunotherapy Market Share by Type (2015 and 2016)
Table UK T-Cell Immunotherapy Sales by Application (2015 and 2016)
Table UK T-Cell Immunotherapy Market Share by Application (2015 and 2016)
Figure Russia T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
Figure Russia T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Russia T-Cell Immunotherapy Sales Price Trend (2012-2017)
Table Russia T-Cell Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Russia T-Cell Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Russia T-Cell Immunotherapy Sales by Type (2015 and 2016)
Table Russia T-Cell Immunotherapy Market Share by Type (2015 and 2016)
Table Russia T-Cell Immunotherapy Sales by Application (2015 and 2016)
Table Russia T-Cell Immunotherapy Market Share by Application (2015 and 2016)
Figure Italy T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
Figure Italy T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Italy T-Cell Immunotherapy Sales Price Trend (2012-2017)
Table Italy T-Cell Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Italy T-Cell Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Italy T-Cell Immunotherapy Sales by Type (2015 and 2016)
Table Italy T-Cell Immunotherapy Market Share by Type (2015 and 2016)
Table Italy T-Cell Immunotherapy Sales by Application (2015 and 2016)
Table Italy T-Cell Immunotherapy Market Share by Application (2015 and 2016)
Figure Spain T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
Figure Spain T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Spain T-Cell Immunotherapy Sales Price Trend (2012-2017)
Table Spain T-Cell Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Spain T-Cell Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Spain T-Cell Immunotherapy Sales by Type (2015 and 2016)
Table Spain T-Cell Immunotherapy Market Share by Type (2015 and 2016)
Table Spain T-Cell Immunotherapy Sales by Application (2015 and 2016)
Table Spain T-Cell Immunotherapy Market Share by Application (2015 and 2016)
Figure Benelux T-Cell Immunotherapy Sales and Growth Rate (2012-2017)
Figure Benelux T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Benelux T-Cell Immunotherapy Sales Price Trend (2012-2017)
Table Benelux T-Cell Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Benelux T-Cell Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Benelux T-Cell Immunotherapy Sales by Type (2015 and 2016)
Table Benelux T-Cell Immunotherapy Market Share by Type (2015 and 2016)
Table Benelux T-Cell Immunotherapy Sales by Application (2015 and 2016)
Table Benelux T-Cell Immunotherapy Market Share by Application (2015 and 2016)
Table T-Cell Immunotherapy Basic Information List
Table Adaptimmune T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Adaptimmune T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Altor Bioscience Corporation Basic Information List
Table Altor Bioscience Corporation T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Altor Bioscience Corporation T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Cellectis Basic Information List
Table Cellectis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Cellectis T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Cell Therapy Catapult Basic Information List
Table Cell Therapy Catapult T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Cell Therapy Catapult T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Juno Therapeutics Basic Information List
Table Juno Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Juno Therapeutics T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Kite Pharma Basic Information List
Table Kite Pharma T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Kite Pharma T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Takara Bio Basic Information List
Table Takara Bio T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Takara Bio T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Unum Therapeutics Basic Information List
Table Unum Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Unum Therapeutics T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Abingworth Basic Information List
Table Abingworth T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abingworth T-Cell Immunotherapy Sales Market Share (2012-2017)
Table ARCH Venture Partners Basic Information List
Table Acorn Campus Ventures Basic Information List
Table Adaptimmune Basic Information List
Table AFA F?rs?kring Basic Information List
Table AGF Private Equity Basic Information List
Table AgonOx Basic Information List
Table Agreen Biotech Basic Information List
Table Aju IB Investment Basic Information List
Table Alaska Permanent Fund Basic Information List
Table Alexandria Ventures Basic Information List
Table Allos Therapeutics Basic Information List
Table Amgen Basic Information List
Table Applied Immune Technologies Basic Information List
Table Aquilo Capital Management Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of T-Cell Immunotherapy
Figure Manufacturing Process Analysis of T-Cell Immunotherapy
Figure T-Cell Immunotherapy Industrial Chain Analysis
Table Raw Materials Sources of T-Cell Immunotherapy Major Manufacturers in 2015
Table Major Buyers of T-Cell Immunotherapy
Table Distributors/Traders List
Figure Germany T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)
Figure Germany T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)
Figure France T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)
Figure France T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)
Figure UK T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)
Figure UK T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)
Figure Russia T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)
Figure Russia T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)
Figure Italy T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)
Figure Italy T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)
Figure Spain T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)
Figure Spain T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)
Figure Benelux T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)
Table Europe T-Cell Immunotherapy Sales Forecast by Type (2017-2022)
Table Europe T-Cell Immunotherapy Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *